Log in to save to my catalogue

Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical pro...

Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical pro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6098033

Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle

About this item

Full title

Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle

Publisher

England: Nature Publishing Group

Journal title

Neuropsychopharmacology (New York, N.Y.), 2018-09, Vol.43 (10), p.2036-2045

Language

English

Formats

Publication information

Publisher

England: Nature Publishing Group

More information

Scope and Contents

Contents

Cannabidiol (CBD), the major non-psychoactive constituent of Cannabis sativa, has received attention for therapeutic potential in treating neurologic and psychiatric disorders. Recently, CBD has also been explored for potential in treating drug addiction. Substance use disorders are chronically relapsing conditions and relapse risk persists for mul...

Alternative Titles

Full title

Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6098033

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6098033

Other Identifiers

ISSN

0893-133X

E-ISSN

1740-634X

DOI

10.1038/s41386-018-0050-8

How to access this item